【Yung Shin】February 2026 Monthly Revenue NT$524 Million (YoY -16.7%)
NQ Score
50/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Taiwan's major pharmaceutical manufacturer, Yung Shin (3705), announced its financial data for February 2026. The company's monthly revenue was NT$524 million, a 16.7% decrease compared to the same period last year. This decline may be related to seasonal factors in pharmaceutical sales or adjustments in national health insurance drug pricing policies, reflecting the operational challenges within the pharmaceutical industry.
AI analysis data is not yet available.